Axonal Transport: Properties, Mechanisms, and Role in Nerve Disease

Peripheral Neuropathy

Volumn 1, Issue , 2005, Pages 387-409

  Brimijoin, Stephen ^a  

^a Mayo Clinic College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882925239     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-9491-7.50021-1     Document Type: Chapter

References (246)

1. Aguayo A.J., Attiwell M., Trecarten J. Abnormal myelination in transplanted trembler mouse Schwann cells. Nature 1977, 265:73.
2. Allen R.D., Travis J.L., Hayden J.H. Cytoplasmic transport: moving ultrastructural elements common to many cell types revealed by video-enhanced microscopy. Cold Spring Harb. Symp. Quant. Biol. 1982, 46:85.
3. Allen R.D., Weiss D.G., Hayden J.H. Gliding movement of and bidirectional transport along single native microtubules from squid axoplasm: evidence for an active role of microtubules in cytoplasmic transport. J. Cell. Biol. 1985, 100:1736.
4. Almenar-Queralt A., Goldstein L.S. Linkers, packages and pathways: new concepts in axonal transport. Curr. Opin. Neurobiol. 2001, 11:550.
5. Anderson D.R. Axonal transport in the retina and optic nerve. Neuro-Ophthalmology 1977, 140. C. V. Mosby, St Louis. J.S. Glaser (Ed.).
6. Anthony D.C., Boekelheide K., Graham D.G. The effect of 3, 4-dimethyl substitution on the neurotoxicity of 2, 5-hexanedione. I. Accelerated clinical neuropathy is accompanied by more proximal axonal swellings. Toxicol. Appl. Pharmacol. 1983, 71:362.
7. Armstrong R., Toews A.D., Morell P. Rapid axonal transport in focally demyelinated sciatic nerve. J. Neurosci. 1987, 7:4044.
8. Asmundson V.S., Kratzer F.H., Julian L.M. Inherited myopathy in the chicken. Ann. N. Y. Acad. Sci. 1966, 138:49.
9. Baas P.E. Microtubule transport in the axon. Int. Rev. Cytol. 2002, 212:41.
10. Bajada S., Sharma A.K., Thomas P.K. Axoplasmic transport in vagal afferent fibers in normal and alloxan-diabetic rabbits. J. Neurol. Sci. 1980, 47:365.
11. Banks P., Mayor D., Tomlinson D. Further evidence for the involvement of microtubules in the intra-axonal movement of noradrenaline storage vesicles. J. Physiol. (Lond.) 1971, 219:755.
12. Banks P., Till R. A correlation between the effects of antimitotic drugs on microtubule assembly in vitro and the inhibition of axonal transport in noradrenergic neurons. J. Physiol. (Lond.) 1975, 252:283.
13. Behrens M.I., Torrealba G., Court J., et al. Axonal transport dysfunction in dystrophia myotonica. Acta Neuropathol. (Berl.) 1983, 62:157.
14. Bird M.T., Shuttleworth J.R., Koestner A., Reinglass J. The wobbler mouse mutant: an animal model of hereditary motor system disease. Acta Neuropathol. (Berl.) 1971, 19:39.
15. Bisby M.A. Orthograde and retrograde axonal transport of labeled protein in motoneurons. Exp. Neurol. 1976, 50:628.
16. Bisby M.A. Retrograde axonal transport of endogenous protein: differences between motor and sensory axons. J. Neurochem. 1977, 28:249.
17. Bisby M.A. Axonal transport of labelled protein and regeneration rate in nerves of streptozotocin-diabetic rats. Exp. Neurol. 1980, 69:74.
18. Bisby M.A. Retrograde axonal transport. Adv. Cell Neurobiol. 1980, 1:69.
19. Blakemore W.F., Cavanagh J.B. quot;Neuroaxonal dystrophy" occurring in the experimental "dying back" process in the rat. Brain 1969, 92:789.
20. Boegman R.J., Aguayo A.J., Bray G.M. Axoplasmic transport in (trembler mouse) nerves with a widespread disorder of myelination. J. Neuropathol. Exp. Neurol. 1977, 36:590.
21. Boegman R.J., Wood P.L. Axonal transport in dystrophic hamsters. Can. J. Physiol. 1981, 59:202.
22. Borchelt D.R., Wong P.C., Becher M.W., et al. Axonal transport of mutant superoxide dismutase 1 and focal axonal abnormalities in the proximal axons of transgenic mice. Neurobiol. Dis. 1998, 5:27.
23. Bowen D.M., Smith C.B., White P., Davison A.N. Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain 1976, 99:459.
24. Bradley W.G., Jaros E. Axoplasmic flow in axonal neuropathies. II. Axoplasmic flow in mice with motor neuron: disease and muscular dystrophy. Brain 1973, 96:247.
25. Bradley W.G., Jenkinson M. Abnormalities of peripheral nerves in murine muscular dystrophy. J. Neurol. Sci. 1973, 18:227.
26. Bradley W.G., Williams M.H. Axoplasmic flow in axonal neuropathies. I. Axoplasmic flow in cats with toxic neuropathies. Brain 1973, 96:235.
27. Brady S.T., Lasek R.J. Fast axonal transport in extruded axoplasm from squid giant axon. Science 1982, 218:1129.
28. Brady S.T., Lasek R.J., Allen R.D. Video microscopy of fast axonal transport in extruded axoplasm: A new model for study of molecular mechanisms. Cell Motil. 1985, 5:81.
29. Braendgaard H., Sidenius P. The retrograde fast component of axonal transport in motor and sensory nerves of the rat during administration of 2, 5-hexanedione. Brain Res. 1986, 378:1.
30. Brat D., Brimijoin S. Acrylamide and glycidamide impair neurite outgrowth in differentiating N1E.115 neuroblastoma without disturbing rapid bidirectional transport of organelles observed by video microscopy. J. Neurochem. 1993, 60:2145.
31. Brat D., Windebank A., Brimijoin S. Emulsifier for intravenous cyclosporin inhibits neurite outgrowth, causes deficits in rapid axonal transport and leads to structural abnormalities in differentiating N1E.115 neuroblastoma. J. Pharmacol. Exp. Ther. 1992, 261:803.
32. Bray J.J., Kon E.M., Breckenridge B.M. Reversed polarity of rapid axonal transport in chicken motoneurons. Brain Res. 1971, 33:560.
33. Breuer A.C., Atkinson M.B. Fast axonal transport alterations in amyotrophic lateral sclerosis (ALS) and in parathyroid hormone (PTH)-treated axons. Cell Motil. Cytoskeleton 1988, 10:321.
34. Breuer A.C., Lynn M.B., Atkinson M.B., et al. Fast axonal transport in amyotrophic lateral sclerosis: an intra-axonal organelle traffic analysis. Neurology 1987, 37:738.
35. Brimijoin S. Stop-flow: a new technique for measuring axonal transport, and its application to the transport of dopamine-β-hydroxylase. J. Neurobiol. 1975, 6:379.
36. Brimijoin S. A histofluorescence study of events accompanying accumulation and migration of norepinephrine within locally cooled nerves. J. Neurobiol. 1977, 8:251.
37. Brimijoin S. On the kinetics and maximal capacity of the system for rapid axonal transport in mammalian neurones. J. Physiol.(Lond.) 1979, 292:325.
38. Brimijoin S. Axonal transport in autonomic nerves: views on its kinetics. Trends in Autonomic Pharmacology 1982, 17. Urban and Schwarzenberg, Baltimore. S. Kalsner (Ed.).
39. Brimijoin S. Microtubules and the capacity of the system for rapid axonal transport. Fed. Proc. 1982, 41:2312.
40. Brimijoin S., Capek P., Dyck P.J. Axonal transport of dopamine-beta-hydroxylase by human sural nerves in vitro. Science 1973, 180:1295.
41. Brimijoin S., Dyck P.J. Axonal transport of dopamine-beta-hydroxylase and acetylcholinesterase in human peripheral neuropathy. Exp. Neurol. 1979, 66:467.
42. Brimijoin S., Dyck P.J., Jakobsen J., Lambert E.H. Axonal transport in human nerve disease and in the experimental neuropathy induced by p-bromophenylacetylurea. Axoplasmic Transport in Physiology and Pathology 1982, 124. Springer-Verlag, Berlin. D.G. Weiss, A. Gorio (Eds.).
43. Brimijoin S., Jablecki C.K. Reduced axonal transport of dopamine-beta-hydroxylase in dystrophic mice: evidence for abnormality of adrenergic nerve cells. Exp. Neurol. 1976, 53:454.
44. Brimijoin S., Lundberg J.M., Brodin E., et al. Axonal transport of substance P in the vagus and sciatic nerves of the guinea pig. Brain Res. 1980, 191:443.
45. Brimijoin S., Olsen J., Rosenson R. Comparison of the temperature-dependence of rapid axonal transport and microtubules in nerves of the rabbit and bullfrog. J. Physiol. (Lond.) 1979, 287:303.
46. Brimijoin S., Wiermaa M.J. Direct comparison of the rapid axonal transport of norepinephrine and dopamine-beta-hydroxylase activity. J. Neurobiol. 1977, 8:239.
47. Brimijoin S., Wiermaa M.J. Rapid axonal transport of tyrosine hydroxylase in rabbit sciatic nerves. J. Physiol. (Lond.) 1977, 120:77.
48. Brimijoin S., Wiermaa M.J. Rapid orthograde and retrograde axonal transport of acetylcholinesterase as characterized by the stop-flow technique. J Physiol (Lond.) 1978, 285:129.
49. Brown A. Axonal transport of membranous and nonmem-branous cargoes: a unified perspective. J. Cell Biol. 2003, 160:817.
50. Brownlees J., Ackerley S., Grierson A.J., et al. Charcot-Marie-Tooth disease neurofilament mutations disrupt neuro-filament assembly and axonal transport. Hum. Mol. Genet. 2002, 11:2837.
51. Burton P.R., Paige J.L. Polarity of axoplasmic micro-tubules in the olfactory nerve of the frog. Proc. Natl. Acad. Sci. U. S. A. 1981, 78:3269.
52. Cai F., Helke C.J. Abnormal PI3 kinase/Akt signal pathway in vagal afferent neurons and vagus nerve of streptozotocin-diabetic rats. Mol. Brain. Res. 2003, 110:234.
53. Carpenter S. Proximal axonal enlargement in motor neuron disease. Neurology 1968, 18:841.
54. Cavanagh J.B. The significance of the "dying back" process in experimental and human neurological diseases. Int. Rev. Exp. Pathol. 1964, 3:219.
55. Cavanagh J.B., Chen F.C.K., Kyu M.H., Ridley A. The experimental neuropathy in rats caused by p-bromo-phenylacetylurea. J. Neurol. Neurosurg. Psychiatry 1968, 31:471.
56. Chretien M., Patey G., Souyri F., Droz B. quot;Acrylamide-induced" neuropathy and impairment of axonal transport of proteins. II. Abnormal accumulations of smooth endoplasmic reticulum at sites of focal retention of fast transported proteins: electron microscope radioautographic study. Brain Res. 1981, 205:15.
57. Collard J.F., Cote F., Julien J.P. Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis. Nature 1995, 375:61.
58. Cote F., Collard J.F., Julien J.P. Progressive neuronopathy in transgenic mice overexpressing the human neurofilament heavy gene: a mouse model of amyotropic lateral sclerosis. Cell 1993, 73:35.
59. Dahlström A. Effect of colchicine on transport of amine storage granules in sympathetic nerves of the rat. Eur. J. Pharmacol. 1968, 5:111.
60. Dahlström A. Axoplasmic transport (with particular respect to adrenergic neurons). Philos. Trans. R. Soc. Lond. [Biol.] 1971, 261:325.
61. De Jonghe P., Mersivanova I., Nelis E., et al. Further evidence that neurofilament light chain gene mutations can cause Charcot-Marie-Tooth disease type 2E. Ann. Neurol. 2001, 49:245.
62. NTR gene expression in lumbar dorsal root ganglia of streptozocin-induced diabetic rats. Diabetes 1998, 47:1779.
63. LNTR protein in lumbar dorsal root ganglia. Mol. Brain Res. 1997, 51:82.
64. Dent W.W., Calloway J.L., Szebenyi G., et al. Reorganization and movement of microtubules in axonal growth cones and developing interstitial branches. J. Neurosci. 1999, 19:8894.
65. DeSantis M., Hoekman T., Limwongse V. Retrograde transport of peroxidase in motor neurons innervating slow and fast twitch muscles: absence of influence between normal and dystrophic chickens. Brain Res. 1977, 119:454.
66. Diezel P.B., Quadbeck G. Nervenschudigung durch p-Bromophenylacetyl-Harnstoff Naunyn Schmiedebergs. Arch. Exp. Pathol. Pharmakol. 1960, 238:534.
67. DiGiamberardino L., Couraud J.Y., Barnard E.A. Normal axonal transport of acetylcholinesterase forms in peripheral nerves of dystrophic chickens. Brain Res. 1979, 160:196.
68. Droz B., Brunetti M., Giamberardino L.D. Selective distribution of axonally transported phospholipids to nerve endings and/or myelin: the case of ethanolamine glyc-erophospholipids. Phospholipids in the Nervous System 1985, 315. Raven Press, New York. L.A. Horrocks (Ed.).
69. Droz B., Giamberardino L.D., Koenig H.L. Contribution of axonal transport to the renewal of myelin phospholipids in peripheral nerves. I. Quantitative radio-autographic study. Brain Res. 1981, 219:57.
70. Dustin P. Microtubules. Microtubules 1984, 1. Springer-Verlag, New York. 2nd ed. P. Dustin (Ed.).
71. Dyck P.J., Conn D.L., Okazaki H. Necrotizing angiopathic neuropathy: Three dimensional morphology of fiber degeneration related to sites of occluded vessels. Mayo Clin. Proc. 1972, 47:461.
72. Edstrom A., Hanson M. Retrograde axonal transport of proteins in vitro in frog sciatic nerves. Brain Res. 1973, 6:311.
73. Edström A., Kanje M., Rusovan A. Orthograde and retrograde axonal transport in the regenerating frog sciatic nerve show different sensitivities to vanadate. Acta Physiol. Scand. 1988, 134:437.
74. Erdmann G., Wiegand H., Wellhoner H.H. Intraaxonal and extraaxonal transport of 125I-tetanus toxin in early local tetanus Naunyn Schmiedebergs. Arch. Pharmacol. 1975, 290:357.
75. Ernfors P., Lee K.F., Kucera J., Jaenisch R. Lack of neurotrophin-3 leads to deficiencies in the peripheral nervous system and loss of limb proprioceptive afferents. Cell 1994, 77:503.
76. Eyer J., McLean W.G., Leterrier J.-F. Effect of a single dose of β,β'-iminodipropionitrile in vivo on the properties of neurofilaments in vitro: comparison with the effect of iminodipropionitrile added directly to neurofilaments in vitro. J. Neurochem. 1989, 52:1759.
77. Fariñas I., Jones K.R., Backus C., et al. Severe sensory and sympathetic deficits in mice lacking neurotrophin-3. Nature 1994, 369:658.
78. Fernyhough P., Diemel L.T., Brewster W.J., Tomlinson D.R. Deficits in sciatic nerve neuropeptide content coincide with a reduction in target tissue nerve growth factor mRNA in streptozotocin-diabetic rats: effects of insulin treatment. Neuroscience 1994, 62:337.
79. Fernyhough P., Diemel L.T., Tomlinson D.R. Target tissue production and axonal transport of neurotrophin-3 are reduced in streptozotocin-diabetic rats. Diabetologia 1998, 41:300.
80. Forman D.S. A permeabilized cell model of saltatory organelle movement. J. Cell Biol. 1981, 91:414a.
81. Forman D.S., Brown K.J., Livengood D.R. Fast axonal transport in permeabilized lobster giant axons is inhibited by vanadate. J. Neurosci. 1983, 3:1279.
82. Forman D.S., Brown K.J., Promersberger M.E. Selective inhibition of retrograde axonal transport by erythro-9[3-(2-hydroxy-nonyl)]adenine. Brain Res. 1983, 272:194.
83. Forman D.S., Padjen A.L., Siggins G.R. Axonal transport of organelles visualized by light microscopy: cinemicro-graphic and computer analysis. Brain Res. 1977, 136:197.
84. Ghetti B., Ochs S. On the relation between microtubule density and axoplasmic transport in nerves treated with maytansine. Peripheral Neuropathies 1978, 177. Elsevier, Amsterdam. N. Canal, G. Pozza (Eds.).
85. Goldberg D.J., Schwartz J.H., Sherbany A.A. Kinetic properties of normal and perturbed axonal transport of serotonin in a single identified axon. J. Physiol. (Lond.) 1978, 281:559.
86. Goldstein S.B., Yang Z.H. Microtubule-based transport systems in neurons: the roles of kinesins and dyneins. Annu. Rev. Neurosci. 2000, 23:39.
87. Grafstein B., Forman D. Intracellular transport in neurons. Physiol. Rev. 1980, 60:1167.
88. Graham D.G., Anthony D.C., Boekelheide K. Studies of the molecular pathogenesis of hexane neuropathy II. Evidence that pyrrole derivatization of lysyl residues leads to protein crosslinking. Toxicol. Appl. Pharmacol. 1982, 64:629.
89. Graham D.G., Szakal-Quin G., Priest J.W., Anthony D.C In vitro evidence that covalent crosslinking of neurofilaments occurs in gamma-diketone neuropathy. Proc. Natl. Acad. Sci. U. S. A. 1984, 81:4979.
90. Green L.S., Donoso J.A., Heller-Bettinge I.E., Samson F.E. Axonal transport disturbances in vincristine-induced peripheral neuropathy. Ann. Neurol. 1977, 1:255.
91. Griffin J.W., Pahnestock K.E., Price D.L., Hoffman P.N. Microtubule-neurofilament segregation produced by β,β'-iminodipropionitrile: evidence for association of fast axonal transport with microtubules. J. Neurosci. 1983, 3:557.
92. Griffin J.W., Gold B.G., Cork L.C. IDPN neuropathy in the cat: coexistence of proximal and distal axonal swellings. Neuropathol. Appl. Neurobiol. 1982, 8:351.
93. Griffin J.W., Hoffman P.N., Clark A.W. Slow axonal transport of neurofilament proteins: impairment by β,β'-iminodipropionitrile administration. Science 1978, 202:633.
94. Griffin J.W., Price D.L. Proximal axonopathies induced by toxic chemicals. Experimental and Clinical Neurotoxicology 1980, 161. Williams & Wilkins, Baltimore. P.S. Spencer, H.H. Schaumberg (Eds.).
95. Griffin J.W., Price D.L., Hoffman P.N., Cork L.C. The axonal cytoskeleton: alterations of organization and axonal transport in models of neurofibrillary pathology [abstract]. J. Neuropathol. Exp. Neurol. 1981, 40:316.
96. Griffin J.W., Price D.L., Spencer P.S. Fast axonal transport through giant axonal swellings in hexacarbon neuropathy. J. Neuropathol. Exp. Neurol. 1977, 36:603.
97. Gupta R.P., Abdel-Rahman A., Wilmarth K.W., Abou-Donia M.B. Alteration in neurofilament axonal transport in the sciatic nerve of the diisopropyl phosphoro-fluoridate (DFP)-treated hen. Biochem. Pharmacol. 1997, 53:1799.
98. Hahnenberger R.W. Effects of pressure on fast axoplasmic flow: an in vitro study in the vagus nerve of rabbits. Acta Physiol. Scand. 1978, 104:299.
99. Hahnenberger R.W. Effect of a pressure barrier on retrograde axoplasmic transport in vitro: a study in the motor neurons of the rabbit vagus. Acta Physiol. Scand. 1980, 108:133.
100. Hammerschlag R. The role of calcium in the initiation of fast axonal transport. Fed. Proc. 1980, 39:2809.
101. Hammerschlag R., Bakhit C., Chiu A.Y. Role of calcium in the initiation of fast axonal transport of protein-effects of divalent cations. J. Neurobiol. 1977, 8:439.
102. Hammerschlag R., Bolen F.A., Stone G.C. Inhibition of fast axonal transport by a sodium ionophore. Trans. Am. Soc. Neurochem. 1980, 11:143.
103. 3H]-protein by cobalt ions. Brain Res. 1976, 114:353.
104. Hammerschlag R., Stone G.C., Bolen F.A. Evidence that all newly synthesized proteins destined for fast axonal transport pass through the Golgi apparatus. J. Cell Biol. 1982, 93:568.
105. Hansen T., Andersen C.B., Echwald S.M., et al. Identification of a common amino acid polymorphism in the p85alpha regulatory subunit of phosphatidylinositol 3-kinase: effects on glucose disappearance constant, glucose effectiveness, and the insulin sensitivity index. Diabetes 1997, 46:494.
106. Harris C.H., Gulati A.K., Friedman M.A., Sickles D.W. Toxic neurofilamentous axonopathies and fast anterograde axonal transport. Part V. Reduced bi-directional vesicle transport in cultured neurons by acrylamide and glycidamide. J. Toxicol. Environ. Health 1994, 42:343.
107. Heidemann S.R., McIntosh J.R. Visualization of the structural polarity of microtubules. Nature 1980, 1286:517.
108. Helland L. Rapid retrograde transport of dopamine-β-hydroxylase as examined by the stop-flow technique. Brain Res. 1976, 102:217.
109. Hirano A., Donnenfeld H., Sasaki S., Nakano I. Fine structural observations of neurofilamentous changes in amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 1984, 43:461.
110. Hoffman P.N., Lasek R.J. The slow component of axonal transport: identification of major structural polypeptides of the axon and their generality among mammalian neurons. J. Cell Biol. 1975, 66:351.
111. Homburger F, Nixon C.W., Eppenberger M., Baker J. Hereditary myopathy in the Syrian hamster: studies on pathogenesis. Ann. N. Y. Acad. Sci. 1966, 138:14.
112. Jablecki C.K., Brimijoin S. Reduced axoplasmic transport of choline acetyltransferase activity in dystrophic mice. Nature 1974, 250:151.
113. Jakobsen J. Axonal dwindling in early experimental diabetes. Diabetologia 1976, 12:539.
114. Jakobsen J. Axonal dwindling in early experimental diabetes. II. A study of isolated nerve fibers. Diabetologia 1976, 12:547.
115. Jakobsen J., Brimijoin S. Axonal transport of enzymes and labeled proteins in experimental axonopathy induced by p-bromophenylacetylurea. Brain Res. 1981, 229:103.
116. Jakobsen J., Brimijoin S., Skau K., Wells D. Retrograde axonal transport of transmitter enzymes, fucose labeled proteins and nerve growth factor in streptozotocin-diabetic rats. Diabetes 1981, 30:797.
117. Jakobsen J., Lambert E., Carlson G., Brimijoin S. Clinical and electrophysiological characteristics of the experimental neuropathy caused by p-bromophenylacetylurea. Exp. Neurol. 1982, 75:158.
118. Jakobsen J., Sidenius P. Decreased axonal flux of retrogradely transported glycoproteins in early experimental diabetes. J. Neurochem. 1979, 33:1055.
119. Jakobsen J., Sidenius P. Decreased axonal transport of structural proteins in streptozotocin diabetic rats. J. Clin. Invest. 1980, 66:292.
120. Jakobsen J., Sidenius P. Early and dose-dependent decrease in retrograde axonal transport in acrylamide-intox-icated rats. J. Neurochem. 1983, 40:447.
121. Kamal A., Stokin G.B., Yang Z., et al. Axonal transport of amyloid precursor protein is mediated by direct binding to the kinesin light chain subunit of kinesin-1. Neuron 2000, 28:449.
122. Kidman A., Hanwell M., Cooper N. Failure of diphtheritic demyelination to block slow axonal transport in chicken sciatic nerve. J. Neurochem. 1979, 33:357.
123. Kirkpatrick J.B., Stern L.Z. Axoplasmic flow in human sural nerve. Arch. Neurol. 1973, 28:308.
124. Kirkpatrick L.L., Witt A.S., Payne H.R., et al. Changes in microtubule stability and density in myelin-deficient shiverer mouse CNS axons. J. Neurosci. 2001, 21:2288.
125. Kirpekar S.M., Prat J.C., Wakade A.R. Metabolic requirements for the intraaxonal transport of noradrenaline in the cat hypogastric nerve. J. Physiol. (Lond.) 1973, 228:173.
126. Klein R., Silos-Santiago I., Smeyne R.J. Disruption of the neurotophin-3 receptor gene TrkC eliminates 1a muscle afferents and results in abnormal movements. Nature 1994, 368:249.
127. Komiya Y, Cooper N.A., Kidman A.D. The long-term effects of a single injection of β,β'-iminodipropionitrile on slow axonal transport in the rat. J. Biochem. 1986, 100:1241.
128. Komiya Y, Austin L. Axoplasmic flow of protein in the sciatic nerve of normal and dystrophic mice. Exp. Neurol. 1974, 43:1.
129. Korthals J.K, Korthals M.A., Wisniewski H.M. Peripheral nerve ischemia: part 2. Accumulation of organelles. Ann. Neurol. 1978, 4:487.
130. Kreutzberg G.W. Neuronal dynamics and axonal flow IV. Blockage of intra-axonal enzyme transport by colchicine. Proc. Natl. Acad. Sci. U. S. A. 1969, 62:722.
131. 14C] 2-deoxyglucose study. Exp. Neurol. 1980, 70:712.
132. Kristensson K. Retrograde transport of macromolecules in axons. Ann. Rev. Pharmacol. Toxicol. 1978, 18:97.
133. Kristensson K, Lycke E., Sjostrand J. Spread of herpes simplex virus in peripheral nerves. Acta Neuropathol. (Berl.) 1971, 19:44.
134. Kuffer A.D., Komiya Y, Austin L. Proteins of fast axoplasmic transport in the sciatic nerve of the dystrophic mouse. Exp. Neurol. 1977, 55:74.
135. Larsen J.R., Sidenius P. Slow axonal transport of structural polypeptides in rat, early changes in streptozocin diabetes, and effect of insulin treatment. J. Neurochem. 1989, 52:390.
136. Lasek R.J. Bidirectional transport of radioactively labelled axoplasmic components. Nature 1967, 216:1212.
137. Lasek R.J., Hoffman P.N. The neuronal cytoskeleton, axonal transport and axonal growth. Cell Motility (Cold Spring Harbor Conferences on Cell Proliferation Series). Cold Spring Harbor 1976, 1021. Cold Spring Harbor Press, NY. R. Goldman, T. Pollard, J. Rosenbaum (Eds.).
138. Lee P.G., Hohman T.C., Cai F, et al. Streptozotocin-induced diabetes causes metabolic changes and alterations in neurotrophin content and retrograde transport in the cervical vagus nerve. Exp. Neurol. 2001, 170:149.
139. Lee W.C., Yoshihara M., Littleton J.T. Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington's disease. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:3224.
140. Leone J., Ochs S. Anoxic block and recovery of axoplasmic transport and electrical excitability of nerve. J. Neurobiol. 1978, 9:229.
141. Liwnicz B.H., Kristensson I., Wisniewski H.M. Observations on axoplasmic transport in rabbits with aluminum-induced neurofibrillary tangles. Brain Res. 1974, 80:413.
142. LoPachin R.M. The role of fast axonal transport in acry-lamide pathophysiology: mechanism of epiphenomenon?. Neurotoxicology 2002, 23:253.
143. Lubinska L. Axoplasmic streaming in regenerating and in normal nerve fibres. Prog. Brain Res. 1964, 13:1.
144. Maeda K., Fernyhough P., Tomlinson D.R. Regenerating sensory neurones of diabetic rats express reduced levels of mRNA for GAP-43, gamma-prepro-tachykinin and the nerve growth factor receptors, trkA and p75NGFR. Mol. Brain Res. 1996, 37:166.
145. Martz D., Gamer J., Lasek R.J. Protein changes during anterograde-to-retrograde conversion of axonally transported vesicles. Brain Res. 1989, 476:199.
146. Marszalek J.R., Williamson T.L., Lee M.K., et al. Neurofilament subunit H modulates axonal diameter by affecting the rate of neurofilament transport. J. Cell Biol. 1996, 135:711.
147. Mayer J.H., Tomlinson D.R. Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats. Diabetologia 1983, 25:433.
148. McComas A.J., Sica R.E.P., Currie S. Muscular dystrophy: evidence for a neural factor. Nature 1970, 226:1263.
149. McEwen B.S., Forman D.S., Grafstein B. Components of fast and slow axonal transport in the goldfish optic nerve. J. Neurobiol. 1971, 2:361.
150. McLane J., McClure W.O. Rapid axoplasmic transport in dystrophic mice. J. Neurochem. 1977, 29:863.
151. McNiven M.A., Ward J.B. Calcium regulation of pigment transport in vitro. J. Cell Biol. 1988, 106:111.
152. Mendell J.R., Sahenk Z., Saida K. Alterations of fast axoplasmic transport in experimental methyl n-butyl ketone neuropathy. Brain Res. 1977, 133:107.
153. Michelson A.M., Russell E.S., Pinckney J.H. Dystrophia muscularis: a hereditary primary myopathy in the house mouse. Proc. Natl. Acad. Sci. U. S. A. 1955, 41:1079.
154. Miller C.C., Ackerley S., Brownlees J., et al. Axonal transport of neurofilaments in normal and disease states. Cell. Mol. Life Sci. 2002, 59:323.
155. Moretto A., Capodicasa E., Peraica M., Lotti M. Age sensitivity to organophosphate-induced delayed polyneuropathy: Biochemical and toxicological studies in developing chicks. Biochem. Pharmacol. 1991, 41:1497.
156. Morgan G., Wilbourn A.J. Cervical radiculopathy and coexisting distal entrapment neuropathies: double-crush syndromes?. Neurology 1998, 50:78.
157. Nagata H., Brimijoin S. Axonal transport in the motor neurons of rats with neuropathy induced by p-bromo-phenylurea. Ann. Neurol. 1986, 19:458.
158. Nagata H., Brimijoin S. Neurotoxicity of halogenated pheylacetylureas is linked to abnormal onset of rapid axonal transport. Brain Res. 1986, 385:136.
159. Nagata H., Brimijoin S., Low P., Schmelzer J.D. Slow axonal transport in experimental hypoxia and in neuropathy induced by p-bromophenylacetylurea. Brain Res. 1987, 422:319.
160. Nagata H., Ohkoshi N., Kanazawa J., et al. Rapid axonal transport velocity is reduced in experimental ethylene oxide neuropathy. Mol. Chem. Neuropathol. 1992, 17:209.
161. Nordberg A., Hellstrom-Lindahl E., Lee M., et al. Chronic nicotine treatment reduces b-amyloidosis in the brain of a mouse model of Alzheimer's disease (APPsw). J. Neurochem. 2002, 81:655.
162. Ochs S. Local supply of energy to the fast axoplasmic transport mechanism. Proc. Natl. Acad. Sci. U. S. A. 1971, 68:1279.
163. Ochs S. Rate of fast axoplasmic transport in mammalian nerve fibres. J. Physiol. (Lond.) 1972, 227:627.
164. Ochs S. Effect of maturation and aging on the rate of fast axoplasmic transport in mammalian nerve. Prog. Brain Res. 1973, 40:349.
165. Ochs S. Axoplasmic transport-energy metabolism and mechanism. The Vertebrate Peripheral Nervous System 1974, 47. Plenum Press, New York. J.I. Hubbard (Ed.).
166. Ochs S. Retention and redistribution of proteins in mammalian nerve fibres by axoplasmic transport. J. Physiol. (Lond.) 1975, 253:459.
167. Ochs S. A unitary concept of axoplasmic transport based on the transport filament hypothesis. Third International Congress on Muscle Diseases 1975, 189. Excerpta Medica, Amsterdam. W.G. Bradley, D. Gardner-Medwin, J.N. Walton (Eds.).
168. Ochs S. Axoplasmic Transport and Its Relation to Other Nerve Functions 1982, Wiley Interscience, New York.
169. Ochs S., Hollingsworth D. Dependence of fast axoplasmic transport in nerve on oxidative metabolism. J. Neurochem. 1971, 18:107.
170. Ochs S., Jersild R.A. Fast axoplasmic transport in nonmyelinated mammalian nerve fibers shown by electron microscopic radioautography. J. Neurobiol. 1974, 5:373.
171. Ochs S., Smith C.B. Fast axoplasmic transport in mammalian nerve in vitro after block of glycolysis with iodoacetic acid. J. Neurochem. 1971, 18:833.
172. Ochs S., Smith C.B. Low temperature slowing and cold-block of fast axoplasmic transport in mammalian nerves in vitro. J. Neurobiol. 1975, 6:85.
173. Ochs S., Worth R.M., Chan S.Y. Calcium requirement for axoplasmic transport in mammalian nerve. Nature 1977, 270:748.
174. Ohnishi A., Schilling K., Brimijoin S., et al. Lead neuropathy. I. Morphometry, nerve conduction and choline acetyl-transferase transport: new finding of endoneurial edema associated with segmental demyelination. J. Neuropathol. Exp. Neurol. 1977, 36:499.
175. Oka N., Brimijoin S. Tubulomembranous lesions in BPAU neuropathy reflect local stasis of fast axonal transport: evidence from electronmicroscope autoradiography. Mayo Clin. Proc. 1992, 67:341.
176. OtsGBRa A.J., Jeyaprakash A., Garcia-Anoveros J., et al. The Celegans unc-104 gene encodes a putative kinesin heavy chain-like protein. Neuron 1991, 6:113.
177. Padilla S., Atkinson M.B., Breuer A.C. Direct measurement of fast axonal organelle transport in the sciaticnerve of rats treated with acrylamide. J. Toxicol. Environ. Health 1993, 39:429.
178. Paschal B.M., Vallee R.B. Retrograde transport by the microtubule associated protein MAP IC. Nature 1987, 330:181.
179. Pierce D.W., Hom-Booher N., OtsGBRa A.J., Vale R.D. Single-molecule behavior of monomeric and heteromeric kinesins. Biochemistry 1999, 38:5412.
180. Pleasure D.E., Mishler K.C., Engel W.K. Axonal transport of proteins in experimental neuropathies. Science 1969, 166:524.
181. Price D.L., Griffin J., Young A. Tetanus toxin: direct evidence for retrograde intraaxonal transport. Science 1975, 88:945.
182. Ramony Cajal S. Degeneration and Regeneration of the Nervous System 1928, Oxford University Press, London. R.M. May (Ed.).
183. Ranvier M.L.L. Leçons sur I'Histologie du Systeme Nerveux 1878, 68. Librairie F. Savy, Paris.
184. Rao M.V., Nixon R.A. Defective neurofilament transport in mouse models of amyotrophic lateral sclerosis: a review. Neurochem. Res. 2003, 28:1041.
185. 125I-beta nerve growth factor in vivo. Brain Res. 1998, 798:67.
186. Rosen D.R., Siddique T., Patterson D., et al. Mutation in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993, 362:59.
187. Roy S., Coffee P., Smith G., et al. Neurofilaments are transported rapidly but intermittently in axons: implications for slow axonal transport. J. Neurosci. 2000, 20:6849.
188. Rydevik B., McLean W.G., Sjöstrand J., Lundborg G. Blockage of axonal transport induced by acute graded compression of the rabbit vagus nerve. J. Neurol. Neurosurg. Psychiatry 1980, Q43:690.
189. Sabri M.I. Further observations on in vitro and in vivo effects of 2, 5-hexanedione on giyceraldehyde-3-phosphate dehydrogenase. Arch. Toxicol. 1984, 55:191.
190. Sabri M.I. In vitro effect of n-hexane and its metabolites on selected enzymes in glycolysis, pentose phosphate pathway and citric acid cycle. Brain Res. 1984, 297:145.
191. Sabri M.I., Moore C., Spencer P.S. Studies on the biochemical basis of distal axonopathies. I. Inhibition of glyceraldehyde-3-phosphate dehydrogenase by neurotoxic hexacarbon compounds. J. Neurochem. 1979, 32:683.
192. Sabri M.I., Ochs S. Relation of ATP and creatine phosphate to fast axoplasmic transport in mammalian nerve. J. Neurochem. 1972, 19:2821.
193. Sabri M.I., Spencer P.S. Toxic distal axonopathy: biochemical studies and hypothetical mechanisms. Experimental and Clinical Neurotoxicology 1980, 206. Williams & Wilkins, Baltimore. P.S. Spencer, H.H. Schaumberg (Eds.).
194. Sahenk Z., Lasek R.J. Inhibition of proteolysis blocks anterograde-to-retrograde conversion of axonally transported vesicles. Brain Res. 1988, 460:199.
195. Sahenk Z., Mendell J.R. Ultrastructural study of zinc pyridinethione-induced peripheral neuropathy. J. Neuropathol. Exp. Neurol. 1979, 38:532.
196. Sahenk Z., Mendell J.R. Axoplasmic transport in zinc pyridinethione neuropathy: evidence for an abnormality in distal turn-around. Brain Res. 1980, 186:343.
197. Sahenk Z., Mendell J.R. Acrylamide and 2, 5-hexane-dione neuropathies: abnormal bidirectional transport rate in distal axons. Brain Res. 1981, 219:397.
198. Saunders N.R., Dziegielewska K., Haggendal C.J., Dahlstrom A.B. Slow accumulation of choline acetyl-transferase in crushed sciatic nerves of the rat. J. Neurobiol. 1973, 4:95.
199. Sayre L.M., Autilio-Gambetti L., Gambetti P.-L. Pathogenesis of
200. Schmidt M.L., Martin J.A., Lee V.M., Trojanowski J.Q. Convergence of Lewy bodies and neu-rofibrillary tangles in amygdala neurons of Alzheimer's disease and Lewy body disorders. Acta Neuropathol (Berl.) 1996, 91:475.
201. Schmidt R.E., Beaudet L.N., Plurad S.B., Dorsey D.A. Axonal cytoskeletal pathology in aged and diabetic human sympathetic autonomic ganglia. Brain Res. 1997, 769:375.
202. 125I] nerve growth factor in ileal mesen-teric nerves in vitro: effect of streptozotocin diabetes. Brain Res. 1986, 378:325.
203. Schmidt R.E., Matschinsky F.M., Godfrey D.A. Fast and slow axoplasmic flow in sciatic nerve of diabetic rats. Diabetes 1975, 24:1081.
204. l25I]-nerve growth factor in rat ileal mesenteric nerves: effect of streptozotocin diabetes. Diabetes 1985, 34:1230.
205. Schroer T.A., Brady S.T., Kelly R.B. Fast axonal transport of foreign synaptic vesicles in squid axoplasm. J. Cell Biol. 1985, 101:568.
206. 125I-tetanus toxin as a tool for tracing fiber connections in the central nervous system: connections of the rostral part of the rat neostriatum. Brain Res. 1977, 126:211.
207. Schwab M.E., Heumann R., Thoenen H. Communication between target organs and nerve cells: retrograde axonal transport and site of action of nerve growth factor. Cold Spring Harb. Symp. Quant. Biol. 1982, 46:125.
208. Schwab M.E., Thoenen H. Selective binding uptake and retrograde transport of tetanus toxin by nerve terminals in the rat iris. J. Cell Biol. 1978, 77:3.
209. Scott F.H. On the relation of nerve cells to fatigue of their nerve fibers. J. Physiol. (Lond.) 1906, 34:145.
210. Seiler W.A., Schelgel R., Mackinnon S., Dellon A.L. Double crush syndrome: experimental model in the rat. Surg. Forum 1983, 34:596.
211. Shah J.V., Cleveland D.W. Slow axonal transport: fast motors in the slow lane. Curr. Opin. Cell Biol. 2002, 14:58.
212. Sickles D.W. Toxic neurofilamentous axonopathies and fast anterograde axonal transport. Part I. The effects of single doses of acrylamide on the rate and capacity of transport. Neurotoxicology 1989, 10:91.
213. Sickles D.W., Stone J.D., Friedman M.A. Fast axonal transport: a site of acrylamide neurotoxicity. Neurotoxicology 2002, 23:223.
214. Sidenius P. The effect of doxorubicin on slow and fast components of the axonal transport system in rats. Brain 1986, 109:885.
215. Sidenius P., Jakobsen J. Axonal transport in early experimental diabetes. Brain Res. 1979, 173:315.
216. Sidenius P., Jakobsen J. Retrograde axonal transport: a possible role in the development of neuropathy. Diabetologia 1981, 20:110.
217. Sidenius P., Jakobsen J. Anterograde axonal transport in rats during intoxication with acrylamide. J. Neurochem. 1983, 40:697.
218. Smith R.S. The short term accumulation of axonally transported organelles in the region of localized lesions of single myelinated axons. J. Neurocytol. 1980, 9:39.
219. Southam E., Thomas P.K., King R.H., et al. Experimental vitamin E deficiency in rats: morphological and functional evidence of abnormal axonal transport secondary to free radical damage. Brain 1991, 114:915.
220. Souyri F., Chretien M., Droz B. quot;Acrylamide-induced" neuropathy and impairment of axonal transport of proteins. I. Multifocal retention of fast transported proteins at the periphery of axons as revealed by light microscope radioautography. Brain Res. 1981, 205:1.
221. Spencer P.S., Sabri M.I., Schaumburg H.H., Moore C. Does a defect in energy metabolism in the nerve fiber cause axonal degeneration in polyneuropathies? Ann. Neurol. 1979, 5:501.
222. Stone J.D., Peterson A.P., Eyer J., et al. Axonal neurofil-aments are non-essential elements of toxicant-induced reductions in fast axonal transport. Part II. Video-enhanced differential interference microscopy in PNS axons. Toxicol. Appl. Pharmacol. 1999, 161:50.
223. Stromska D., Ochs S. Patterns of slow transport in the sensory nerves. J. Neurobiol. 1981, 12:441.
224. Tang B.Y., Komiya Y., Austin L. Axoplasmic flow of phospholipids and cholesterol in the sciatic nerve of normal and dystrophic mice. Exp. Neurol. 1974, 43:13.
225. Tetzlaff W., Kreutzberg G.W. Ornithine decarboxylation in motoneurons during regeneration. Exp. Neurol. 1985, 89:679.
226. Tomlinson D.R., Mayer J.H. Reversal of deficits in axonal transport and nerve conduction velocity by treatment of streptozotocin-diabetic rats with myo-inositol. Exp. Neurol. 1985, 89:420.
227. Tomlinson D.R., Sidenius P., Larsen J.R. Slow component-a of axonal transport, nerve myo-inositol, and aldose reductase inhibition in streptozocin-diabetic rats. Diabetes 1985, 35:398.
228. Tomlinson D.R., Townsend J., Fretten P. Prevention of defective axonal transport in streptozocin-diabetic rats by treatment with "Statil" (ICI 128436), an aldose reductase inhibitor. Diabetes 1985, 34:970.
229. TsGBRita S., Ishikawa H. The movement of membranous organelles in axons: electron microscopic identification of anterogradely and retrogradely transported organelles. J. Cell Biol. 1980, 84:513.
230. Tu P.-H., Raju P., Robinson K.A., et al. Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:3155.
231. Upton A.R., McComas A.J. The double crush in nerve entrapment syndromes. Lancet 1973, 2:359.
232. Wakabayashi M., Araki K., Takahashi Y. Increased rate of fast axonal transport in methylmercury-induced neuropathy. Brain Res. 1976, 117:524.
233. Waller A. Experiments on the section of glossopharyngeal and hypoglossal nerves of the frog and observations of the alternatives produced thereby in the structure of their primitive fibers. Philos. Trans. R. Soc. Lond. 1850, 140:423.
234. Wang L., Brown A. Rapid intermittent movement of axonal neurofilaments observed by fluorescence photo-bleaching. Mol. Biol. Cell 2001, 12:3257.
235. Wang L., Brown A. Rapid movement of microtubules in axons. Curr. Biol. 2002, 12:1496.
236. Warita H., Itoyama Y., Abe K. Selective impairment of fast anterograde axonal transport in the peripheral nerves of asymptomatic transgenic mice with a G93A mutant SOD1 gene. Brain Res. 1999, 819:120.
237. Weiss H.D., Walker M.D., Wiernik P.H. Neurotoxicity of commonly used antineoplastic drugs. N Engl. J. Med. 1974, 291:127.
238. Whitely S.J., Townsend J., Tomlinson D.R., Brown A.M. Fast orthograde axonal transport in sciatic motoneurones and nerve temperature in streptozotocin-diabetic rats. Diabetologia 1985, 28:8471.
239. Willard M., Cowan W.M., Vagelos P.R. The polypeptide composition of intra-axonally transported proteins: evidence for four transport velocities. Proc. Natl. Acad. Sci. U. S. A. 1974, 71:2183.
240. Willard M.B., Hulebak K.L. The intra-axonal transport of polypeptide H: evidence for a fifth (very slow) group of transported proteins in the retinal ganglion cells of the rabbit. Brain Res. 1977, 36:289.
241. Williamson T.L., Cleveland D.W. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nat. Neurosci. 1999, 2:50.
242. Wong P.C., Pardo C.A., Borchelt D.R., et al. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 1995, 14:1104.
243. Xu Z., Cork L.C., Griffin J.W., Cleveland D.W. Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease. Cell 1993, 73:23.
244. Yitadello M., Filliatreau G., Dupont J.L. Altered axonal transport of cytoskeletal proteins in the mutant diabetic mouse. J. Neurochem. 1985, 45:860.
245. Zhang F., Eckman C., Younkin S., et al. Increased susceptibility to ischemic brain damage in transgenic mice overexpressing the amyloid precursor protein. J. Neurosci. 1997, 17:7655.
246. Zhao C., Takita J., Tanaka Y, et al. Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bβ. Cell 2001, 105:587.